http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040105765-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-18 |
| filingDate | 2003-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040105765-A |
| titleOfInvention | Process for synthesizing chiral N-aryl piperazines |
| abstract | The present invention relates to a process for the formation of N-aryl piperazine having chiral side chains of formula (IX) and to the preparation of intermediates for the preparation of such compounds. In this method, chiral is introduced in the piperazine ring forming step and 2-aminopyridyl substituents are incorporated via substitution reactions. The resulting N, N'-disubstituted piperazine acts on the central nervous system at the 5HT receptor.n n n Formula IX |
| priorityDate | 2002-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.